These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15549333)

  • 1. Exclusive induction of tau2 epitope in microglia/macrophages in inflammatory lesions-tautwopathy distinct from degenerative tauopathies.
    Uchihara T; Duyckaerts C; Seilhean D; Nakamura A; Lazarini F; Hauw JJ
    Acta Neuropathol; 2005 Feb; 109(2):159-64. PubMed ID: 15549333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial tau undergoes phosphorylation-independent modification after ischemia.
    Uchihara T; Nakamura A; Arai T; Ikeda K; Tsuchiya K
    Glia; 2004 Jan; 45(2):180-7. PubMed ID: 14730711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible conformational change of tau2 epitope on exposure to detergent in glial cytoplasmic inclusions of multiple system atrophy.
    Shibuya K; Uchihara T; Nakamura A; Ishiyama M; Yamaoka K; Yagishita S; Iwabuchi K; Kosaka K
    Acta Neuropathol; 2003 May; 105(5):508-14. PubMed ID: 12677452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms.
    Tolnay M; Sergeant N; Ghestem A; Chalbot S; De Vos RA; Jansen Steur EN; Probst A; Delacourte A
    Acta Neuropathol; 2002 Oct; 104(4):425-34. PubMed ID: 12200631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis.
    Kawamoto Y; Akiguchi I; Kovács GG; Flicker H; Budka H
    Acta Neuropathol; 2004 Feb; 107(2):137-43. PubMed ID: 14605832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Tsuchiya K; Nakamura A; Akiyama H
    Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
    Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains.
    Sasaki K; Shimura H; Itaya M; Tanaka R; Mori H; Mizuno Y; Kosik KS; Tanaka S; Hattori N
    FEBS Lett; 2009 Jul; 583(13):2194-200. PubMed ID: 19527721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peculiar constellation of tau pathology defines a subset of dementia in the elderly.
    Kovacs GG; Molnár K; László L; Ströbel T; Botond G; Hönigschnabl S; Reiner-Concin A; Palkovits M; Fischer P; Budka H
    Acta Neuropathol; 2011 Aug; 122(2):205-22. PubMed ID: 21437732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective deposition of 4-repeat tau in cerebral infarcts.
    Ichihara K; Uchihara T; Nakamura A; Suzuki Y; Mizutani T
    J Neuropathol Exp Neurol; 2009 Sep; 68(9):1029-36. PubMed ID: 19680140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation and cleavage of tau in non-AD tauopathies.
    Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI
    Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon 3 insert of tau protein in neurodegenerative diseases.
    Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
    Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
    Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visualization of tau isoforms by splicing-site specific antibodies].
    Mori H
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1104-6. PubMed ID: 12235809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of the minimal epitope of monoclonal antibody Tau-1 depends upon the presence of a phosphate group but not its location.
    Szendrei GI; Lee VM; Otvos L
    J Neurosci Res; 1993 Feb; 34(2):243-9. PubMed ID: 7680727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.